Early outcome of in situ femorotibial reconstruction among patients with diabetes alone versus diabetes and end-stage renal failure: Analysis of 83 limbs

被引:38
作者
Hakaim, AG
Gordon, JK
Scott, TE
机构
[1] Boston Univ, Sch Med, Boston Med Ctr, Dept Surg,Sect Vasc Surg & Organ Transplantat, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Surg, Sect Surg Res, Boston, MA 02118 USA
[3] Vet Affairs Med Ctr, Surg Serv, Boston, MA USA
关键词
D O I
10.1016/S0741-5214(98)70008-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Both end-stage renal disease and diabetes have been demonstrated to have a negative effect on the outcome of infrainguinal arterial reconstruction, primarily because of increased perioperative morbidity and wound complications. This study was undertaken to determine whether the combination of these comorbid factors affects the outcome of distal arterial reconstruction. Methods: Eighty-three distal lower extremity arterial bypasses originating from the femoral artery and terminating at the peroneal, anterior, or posterior tibial artery were performed on 76 patients over a 5-year period at a tertiary care medical center. Autogenous greater saphenous vein was used as the bypass conduit in all instances. Combined inflow and composite vein procedures were excluded. Results: There was one perioperative death, for a mortality rate of 1.2%. The diabetes mellitus (DM) plus end-stage renal disease (DM+ESRD) cohort displayed a significantly lower 1-year primary patency rate compared with the diabetes mellitus cohort, 53% versus 82% (p < 0.02). However, the limb salvage rate for the DM+ESRD and DM cohorts during the same time interval were not significantly different, 63% versus 84% (p < 0.06). The 52% 1-year survival rate for the DM+ESRD cohort was strikingly lower than the 90% 1-year survival rate for the DM cohort (p < 0.002). Conclusion: Despite the use of the optimal autogenous conduit, the combination of diabetes and end-stage renal disease can be expected to significantly decrease primary graft patency without affecting limb salvage. The greatest effect of these comorbid factors is on patient survival.
引用
收藏
页码:1049 / 1054
页数:6
相关论文
共 24 条
[1]   Diabetes mellitus: A risk factor for carotid endarterectomy? [J].
Akbari, CM ;
Pomposelli, FB ;
Gibbons, GW ;
Campbell, DR ;
Freeman, DV ;
LoGerfo, FW .
JOURNAL OF VASCULAR SURGERY, 1997, 25 (06) :1070-1076
[2]   INFRAINGUINAL BYPASS IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
BAELE, HR ;
PIOTROWSKI, JJ ;
YUHAS, J ;
ANDERSON, C ;
ALEXANDER, JJ .
SURGERY, 1995, 117 (03) :319-324
[3]   PROSTACYCLIN RELEASE FROM THE HUMAN SAPHENOUS-VEIN IN DIABETICS IS LOWER THAN IN NONDIABETICS [J].
BRUNKWALL, JS ;
BERGQVIST, D .
WORLD JOURNAL OF SURGERY, 1992, 16 (06) :1141-1146
[4]  
CHANG BB, 1990, SURGERY, V108, P742
[5]   RESULTS OF LOWER-EXTREMITY AMPUTATIONS IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
DOSSA, CD ;
SHEPARD, AD ;
AMOS, AM ;
KUPIN, WL ;
REDDY, DJ ;
ELLIOTT, JP ;
WILCZEWSKI, JM ;
ERNST, CB .
JOURNAL OF VASCULAR SURGERY, 1994, 20 (01) :14-19
[6]  
EDWARDS JM, 1988, ARCH SURG-CHICAGO, V123, P1164
[7]   END-STAGE RENAL-DISEASE - IS INFRAINGUINAL LIMB REVASCULARIZATION JUSTIFIED [J].
HARRINGTON, EB ;
HARRINGTON, ME ;
SCHANZER, H ;
HAIMOV, M .
JOURNAL OF VASCULAR SURGERY, 1990, 12 (06) :691-696
[8]   FAILURE OF FOOT SALVAGE IN PATIENTS WITH END-STAGE RENAL-DISEASE AFTER SURGICAL REVASCULARIZATION [J].
JOHNSON, BL ;
GLICKMAN, MH ;
BANDYK, DF ;
ESSES, GE .
JOURNAL OF VASCULAR SURGERY, 1995, 22 (03) :280-286
[9]   PERIPHERAL VASCULAR BYPASS IN JUVENILE-ONSET DIABETES-MELLITUS - ARE AGGRESSIVE REVASCULARIZATION ATTEMPTS JUSTIFIED [J].
KWOLEK, CJ ;
POMPOSELLI, FB ;
TANNENBAUM, GA ;
BROPHY, CM ;
GIBBONS, GW ;
CAMPBELL, DR ;
FREEMAN, DV ;
MILLER, A ;
LOGERFO, FW .
JOURNAL OF VASCULAR SURGERY, 1992, 15 (02) :394-401
[10]  
Leschke M, 1997, CLIN HEMORHEOL MICRO, V17, P59